[
    "{\"step_by_step_thinking\": \"Tisagenlecleucel is a medication indicated for the treatment of B-cell lymphomas, including B-cell precursor acute lymphoblastic leukemia (ALL) and diffuse large B-cell lymphoma (DLBCL), as mentioned in Document [0], Document [2], and Document [3]. The effectiveness of Tisagenlecleucel in treating B-cell lymphomas is supported by several studies. For instance, Document [22] reports that Tisagenlecleucel showed high rates of durable responses in patients with relapsed or refractory diffuse large B-cell lymphoma. Document [30] also states that Tisagenlecleucel is safe and effective for adults with relapsed/refractory B-cell acute lymphoblastic leukemia. Therefore, based on the provided documents, Tisagenlecleucel is effective for B-Cell Lymphoma.\", \"answer_choice\": \"A\"}"
]